Correlation Between Molecular Partners and Mind Medicine

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and Mind Medicine, you can compare the effects of market volatilities on Molecular Partners and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Mind Medicine.

Diversification Opportunities for Molecular Partners and Mind Medicine

0.22

Correlation Coefficient

Molecular Partners  Mind Medicine

Modest diversification

The 3 months correlation between Molecular and Mind is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Molecular Partners i.e., Molecular Partners and Mind Medicine go up and down completely randomly.

Pair Corralation between Molecular Partners and Mind Medicine

Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Mind Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 1.31 times less risky than Mind Medicine. The stock trades about -0.01 of its potential returns per unit of risk. The Mind Medicine is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  670.00  in Mind Medicine on December 29, 2024 and sell it today you would lose (27.00) from holding Mind Medicine or give up 4.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Molecular Partners AG  vs.  Mind Medicine

Molecular Partners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Molecular Partners is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Mind Medicine

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Mind Medicine is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Molecular Partners and Mind Medicine

The main advantage of trading using opposite Molecular Partners and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.

The idea behind Molecular Partners AG and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.